3 panauhan Ducks forward Trevor Zegras has surgery on torn knee meniscus, will be out for 6 weeksSocial media users, brace yourselves. Your timeline is about to be flooded with high school coaches looking to fill out their 2025 schedules. Such tends to happen whenever the TSSAA releases its region football schedules, especially whenever realignments are involved. William Blount’s move down to 5A left a void in Region 1-6A, a void which evidently won’t be filled. With a five-team Big East Conference, that leaves each school with six non-region games to be filled. Thankfully, the rivalry between Science Hill and Dobyns-Bennett didn’t get moved. It’ll still be in Week 11 for the next two years anyway, this time on Thursday, Oct. 30. Other than that game, Dobyns-Bennett must build the rest of its schedule around three straight region games against Morristown East, West Ridge and Jefferson County from Sept. 19 to Oct. 3. The Indians requested an open date following the Jeff County game, leaving two more weeks to fill before playing Science Hill first straight non-conference tilts to open the year. Science Hill is scheduled to play Morristown East and Jefferson County back-to-back weeks also — Weeks 6 and 7. That means the Hilltoppers won’t play a region game until Sept. 26 — also the date West Ridge opens Big East play against D-B. The Wolves close the 2025 and 2026 regular seasons with three straight region games. Not to mention, only one team in the Big East will miss the Class 6A playoffs. Of course, few teams have it as tough as Happy Valley and the Warriors’ Region 1-2A rivals — South Greene, West Greene and Cumberland Gap. All four teams are already in the playoffs under the current format. And while Happy Valley can presumably fill its non-region slate with Carter County rivals Hampton, Unaka and Cloudland, that still leaves four non-conference openings. BACK IN ITS RIGHTFUL PLACE What better lead-in to that tradition rich rivalry between D-B and Science Hill than the Musket Bowl? That’s right, in 2025, the annual meeting between Daniel Boone and David Crockett returns to its rightful October place. It’ll stay at Crockett this fall, except this time, the teams will meet Friday, Oct. 24 (Week 10). Granted, the Hawkins County Super Bowl might have something to say about that, as Cherokee and Volunteer meet in Church Hill that same night. On that note, while Regions 1-5A and 1-3A remained unchanged with five region contests and five more out-of-conference, Region 1-4A is in a completely different situation. Each team there needs only three non-region games after Seymour joined the conference. Same in Region 1-1A for that matter. Cloudland opens the year with three non-conference games in as many weeks, finishing the year with seven straight region contests. This became possible after Sunbright relocated from Region 2, and Hampton moved down from Class 2A, of course. THANKSGIVING BASKETBALL CONTINUES With Greeneville falling 28-14 at Anderson County in the Class 4A quarterfinal round, the Tri-Cities area has only one football team remaining — Rye Cove. The War Eagles entertain Eastside in the Region 1D championship round Friday night at the Eagles’ Nest. Thanksgiving week also means tournament time. In addition to the Hardee’s Classic, currently taking place at David Crockett, two other local tournaments also allow teams to get some games in this week. Monday marked opening night for the Food City Thanksgiving Classic at Sullivan East, this year consisting of just boys teams. On the girls side, Happy Valley is hosting the Valley Forge Auction Thanksgiving Classic, which begins with four games on Wednesday afternoon and concludes Saturday. On the web, these tournament schedules can found on the left (desktop) or below (mobile). In print, they can be found on page B2.

Ducks forward Trevor Zegras has surgery on torn knee meniscus, will be out for 6 weeksLabor eyes last chance of 2024 to tick policy boxes

Notre Dame puts losing streak in past, turns focus to DartmouthMinister for Justice praises Nikita Hand’s bravery after victory in civil action against Conor McGregor

Bill Maher will always have a blind spot when it comes to Donald Trump because of his rampant TDS, but with many other political issues, he is recently sounding a lot saner than most liberals on television. After the presidential election, he was frank about why Democrats lost so 'bigly' and warned that they would keep losing if they didn't stop with their intellectual incest. Advertisement Maher also has accurately described many on the left as snobs which is why no one likes them, and accused Democrats of being so left-wing, they fly in circles. Last night, Maher aired the season finale of his HBO show Real Time, and one of his guests—professional thief of joy Neil deGrasse Tyson—provided a perfect illustration of the left's negative attributes. The two were discussing the topics of men in women's sports and the disgraced magazine Scientific American when Maher DROPPED Tyson for refusing to acknowledge the problems related to either one. Watch: Neil deGrasse Tyson Embarrasses Himself as Bill Maher Exposes Disgraceful Scientific American Article "Well, I'm gonna file you under part of the problem." The article claimed that the "inequity" between male and female athletes isn't because of natural biological differences... pic.twitter.com/DqDrul4DT1 — The Vigilant Fox 🦊 (@VigilantFox) November 23, 2024 'Part of the problem.' That describes Tyson perfectly. Good for Maher for not letting Tyson derail the conversation by claiming that 'just one editor' is saying these things. Tyson knows that is not true, and Maher knows he knows it. And it was yet another in a long string of embarrassing moments for Tyson who has shown that he is not capable of having an honest discussion with anyone who disagrees with him. Whoever his agent is should drop him first. The extent to which @neiltyson is a buffoon is immeasurable and even @billmaher is starting to realize it. Ok, I'm really going to bed now!... Grateful CalvinChuck Woolery Dies: Former ‘Wheel of Fortune’ and ‘Love Connection’ Host Was 83

Two of the best programs in college basketball history collide in Las Vegas Tuesday night, as the top-ranked Kansas Jayhawks battle the No. 11 Duke Blue Devils . The game is scheduled to start at 9 p.m. ET ( with TV coverage on ESPN and streaming on-demand . How to watch: Live streams of the Kansas vs. Duke game are available with offers from FuboTV (free trial) , SlingTV (low intro rate) and DirecTV Stream (free trial) . For a limited time, FuboTV is offering $30 off the first month after the free trial period. With $30 offer, plans start at $49.99. #1 Kansas Jayhawks (5-0) vs. #11 Duke Blue Devils (4-1) Vegas Showdown matchup at a glance When: Tuesday, Nov. 26 at 9 p.m. ET (6 p.m. PT) Where: T-Mobile Arena, Las Vegas, Nev. TV channel: ESPN Live streams: FuboTV (free trial) | SlingTV (low intro rate) | DirecTV Stream (free trial) Kansas already has significant wins over then-No. 9 North Carolina (92-89) and Michigan State (92-89), along with three more victories all by double-digit points. Last time out, the Jayhawks rode a balanced offense and a 15-point, 15-rebound double-double from Hunter Dickinson to an 84-66 win over UNC-Wilmington last Tuesday night. Duke comes off its best win of the season over then-No. 17 Arizona last Friday night. That victory was another meaningful step between the Blue Devils and their lone loss to then-No. 19 Kentucky (77-72) earlier this month. Freshman guard Cooper Flagg has backed up the considerable hype by leading Duke in scoring (17.8), rebounding (8.8 rpg), assists (3.8 apg), blocks (1.8 bpg) and steals (1.8 spg). RECOMMENDED • pennlive .com How to watch #12 Duke vs. #17 Arizona basketball: Time, TV channel, FREE live stream Nov. 22, 2024, 6:30 p.m. How to watch #16 Colorado Buffaloes vs. Kansas football: Time, TV channel, FREE live streams Nov. 23, 2024, 12:02 p.m. Kansas Jayhawks vs. Duke Blue Devils: Know your live streaming options FuboTV (free trial) - excellent viewer experience with huge library of live sports content; free trial lengths vary; monthly rate after free trial starts at $49.99 after current $30 discount offer. SlingTV (low intro rate) - discounted first month is best if you’ve run out of free trials or you’re in the market for 1+ month of TV DirecTV Stream (free trial) - not the same level of viewer experience as FuboTV, but the standard 7-day free trial is still the longest in streaming. The Jayhawks and Blue Devils are set for a 9 p.m. ET start on ESPN. Live streams are available from FuboTV (free trial) , DirecTV Stream (free trial) and SlingTV (low intro rate) .

'Some clown': Fan 'abuse' mars Eddie's Twickenham return

And single people are more likely to use mobility tools compared to those who are married, according to researchers from University College London (UCL) and the London School of Hygiene and Tropical Medicine (LSHTM). Researchers looked at information from a group of more than 12,000 adults in England aged 50 to 89 who were tracked over a 13-year period. At the start of the study, 8,225 adults had no mobility difficulty and did not use mobility assistive products (MAPs). Some 2,480 were deemed to have “unmet need” and 1,375 were using mobility aids. During the follow-up period, there were 2,313 “transitions” where people went from having no mobility issues to needing some help with getting around. And 1,274 people started to use mobility aids. Compared with men, women were 49% more likely to transition from not needing mobility aids to needing to use them, according to the study which has been published in The Lancet Public Health. But were 21% less likely to go on to use mobility aids when they needed them. The authors said their study showed “barriers to access” for women. For both men and women, with every year that passed during the study period the need for mobility aids increased. People who were older, less educated, less wealthy or reported being disabled were more likely to “transition from no need to unmet need, and from unmet need to use”, the authors said, with this indicating a “higher prevalence of mobility limitations and MAP need overall among these groups”. They added: “Finally, marital or partnership status was not associated with transitioning to unmet need; however, single people were more likely to transition from unmet need to use compared with married or partnered people.” Jamie Danemayer, first author of the study from UCL Computer Science and UCL’s Global Disability Innovation Hub, said: “Our analysis suggests that there is a clear gender gap in access to mobility aids. “Though our data didn’t ascertain the reason why participants weren’t using mobility aids, other research tells us that women are often more likely than men to face obstacles such as cost barriers as a result of well-documented income disparities between genders. “Many mobility aids are designed for men rather than women, which we think may be a factor. “Using mobility aids can also make a disability visible, which can impact the safety and stigma experienced by women, in particular. “There’s a critical need for further research to identify and break down the barriers preventing women from accessing mobility aids that would improve their quality of life.” Professor Cathy Holloway, also from UCL, added: “Not having access to mobility aids when a person needs one can have a big impact on their independence, well-being and quality of life. “Our analysis suggests that women, in particular, regardless of other factors such as education and employment status, are not getting the support that they need.” Professor Shereen Hussein, senior author of the study and lead of the social care group at the London School of Hygiene & Tropical Medicine, said: “The research provides compelling evidence of gender disparities in accessing assistive technology, suggesting that cost, design bias, and social stigma are likely to disproportionally affect women. “This underscores the need for inclusive, gender-sensitive approaches in the design, production and inclusivity of assistive technologies.”NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it has drawn down the final tranche of €5 million (“Tranche C”) under the credit facility agreement for up to €40 million entered into with the European Investment Bank (the “EIB) on December 28, 2022 (the "Finance Contract"). With the drawdown of Tranche C, the Company has drawn down the full €40 million available under the Finance Contract. Tranche C is expected to be disbursed by the EIB by December 18, 2024. The Company plans to use the proceeds of Tranche C towards the development of its pipeline of allogeneic CAR T-cell product candidates: UCART22 and UCART20x22. As a condition to the disbursement of Tranche C the Company issued 611,426 warrants to the benefit of the EIB, in accordance with the terms of the 14 th resolution of the shareholders’ meeting held on June 28, 2024 and articles L. 228-91 and seq. of the French Commercial Code (the “Tranche C Warrants”). Each Tranche C Warrant allows the EIB to subscribe for one ordinary share of the Company, at a price of €1.70, corresponding to 99% of the volume-weighted average price of the Company’s ordinary shares over the last 3 trading days preceding the decision of the board of directors of the Company to issue the Tranche C Warrants. The total number of shares issuable upon exercise of the Tranche C Warrants represent circa 0.6% of the Company’s outstanding share capital as at their issuance date. Tranche C will mature six years from its disbursement date and will accrue interest at a rate of 6% per annum capitalized annually and payable at maturity. The other terms of the Tranche C Warrants and prepayment events of Tranche C under the Finance Contract are as set forth in the Company’s press release of April 4, 2023 and Form 6-K filed with the U.S. Securities and Exchange Commission on such date. About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with 25 years of experience and expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN ® , its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to treat diseases with unmet medical needs. Cellectis’ headquarters are in Paris, France, with locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit our website: www.cellectis.com Follow Cellectis on social networks @cellectis on LinkedIn and X (formerly Twitter) TALEN® is a registered trademark owned by Cellectis. Cautionary Statement This press release contains “forward-looking” statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expect,” “plan,” and “will,” or the negative of these and similar expressions. These forward-looking statements, which are based on our management’s current expectations and assumptions and on information currently available to management. Forward-looking statements include statements about the date of disbursement of the Tranche C and the use of the proceeds of amounts received under the Finance Contract. These forward-looking statements are made in light of information currently available to us and are subject to numerous risks and uncertainties, including with respect to the numerous risks associated with market conditions, and our ability to satisfy the conditions precedent under the Finance Contract. Furthermore, many other important factors, including those described in our Annual Report on Form 20-F as amended and in our annual financial report (including the management report) for the year ended December 31, 2023 and subsequent filings Cellectis makes with the Securities Exchange Commission from time to time, which are available on the SEC’s website at www.sec.gov , as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Interim Chief Financial Officer, investors@cellectis.com Attachment 20241128_Cellectis_BEI_Tranche C_ENGLISH_PR-MBT

Austin Ekeler injury update: Commanders' RB exits after big hit vs. CowboysNoneNatick next up to vote on rules similar to other Massachusetts sanctuary cities

None45 Medical Laboratory Science students of Al-Hikmah University, Ilorin, Kwara State were Tuesday inducted into the Medical Laboratory Science Council of Nigeria (MLSCN.) The third set to be inducted since the inception of the school in 2004, was also issued with a provisional licence of practice. According to the Head of Department (HOD) MLS, Professor Shola Babatunde, of the 45 inductees presented for the final professional MLSCN examination, “32 emerged with Second-Class honours (Upper Division) and 13 with Second-Class honours (Lower Division.) The disclosure was made at the Oath-Taking/Induction ceremony of the students at the school’s auditorium in Adeta, Ilorin. The HOD hinted that the provisional licence was to enable the inductees to proceed to the one-year mandatory internship programme. He charged the students to: “employ integrity, honesty, diligence, and perseverance. Let the knowledge you have acquired from this great university serve as an instrument to serve humanity, not to exploit it.” Also speaking, the Dean, faculty of health sciences, Prof. Olabode Kayode commended the Vice-Chancellor (VC) of the school, Prof. Noah Yusuf and the entire management for providing the enabling environment for both the teachers and the students to succeed. He charged the new inductees not to forget the department and the school, saying: “There are many ways for you to improve the lives and conditions of those you are leaving behind as well as help reposition Al-Hikmah University as one of the best global practices in MLS.” However, the founder and chairman Board of Trustees (BoT) of the school, Dr. AbdulRaheem Oladimeji, who donated N2 million to the MLS department, urged the inductees to act within the confine of their regulatory/professional governing body. Represented by the Acting Deputy Vice-Chancellor, Dr Sikiru Lanre Nurudeen, the founder, said: “it is important to comply with the noble ethics of your profession. I advise you to operate within the benchmarks and standard operating procedures set by your regulatory body.” The Vice-Chancellor, Prof. Noah Yusuf appreciated Governor AbdulRahman AbdulRazaq for granting the school the leave to use the state’s general hospital, Sobi, as the school’s Teaching Hospital, which he said had elevated the school’s status. He commended the parents for their undying love for their children, describing their love and affection for the inductees as unequal and unmatchable. Speaking on the theme: innovation and technology in medical Laboratory Science Practice: Prospects and challenges,” the keynote Speaker, Prof. Abdulrazaq Nuhu, the Dean, Faculty of Allied Health Sciences, Kwara State University Malete, urged the inductees to leverage the Artificial Intelligence (AI) in their professional routine disposition.

Women more likely to need walking aids but less likely to use them – studyCop29 climate deal criticised as a ‘death sentence for millions’